S&P 및 Nasdaq 내재가치 문의하기

Alpha Tau Medical Ltd. DRTSW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Alpha Tau Medical Ltd. (DRTSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

애널리스트 추정 주당순이익(EPS) $-0.45 및 매출 $0.00B 다음 회계연도.

주당순이익(EPS) 실적 추이: 2024: 실적 $-0.45 vs 추정 $-0.45 (상회 +0%). 2025: 실적 $-0.53 vs 추정 $-0.51 (하회 -3.8%). 애널리스트 정확도: 98%.

EPS 전망 — DRTSW

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.45 vs Est –$0.45 ▼ 0.0% off
2025 Actual –$0.53 vs Est –$0.51 ▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

매출 전망 — DRTSW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기